Examining the expression of low-density lipoprotein receptor (LDLR) and low-density lipoprotein receptor-related protein 6 (LRP6) genes in breast cancer cell lines
Journal: Molecular Biology Research Communications (Vol.13, No. 2)Publication Date: 2024.06.01
Authors : Hamid Behrouj; Mehran Erfani; Pooneh Mokarram;
Page : 85-88
Keywords : Breast cancer; Cholesterol; Wnt/β-catenin signaling; LDLR; LRP6;
- Examining the expression of low-density lipoprotein receptor (LDLR) and low-density lipoprotein receptor-related protein 6 (LRP6) genes in breast cancer cell lines
- Relations Between Atherogenic Index of Plasma, Ratio of Small Dense Low Density Lipoprotein/Lecithin Cholesterol Acyl Transferase and Ratio of Small Dense Low Density Lipoprotein/Cholesteryl Ester Transfer Protein of Controlled and Uncontrolled Type 2 DM
- Correlation Of Oncotype DX Recurrence Score With The Expression Of Insulin Receptor Substrate Proteins In Estrogen Receptor + Breast Cancer
- Molecular Evaluation of Subtypes of Breast Cancer by Immunohistochemical expression of Estrogen Receptor(ER), Progesterone Receptor(PR), Her2neu,Cytokeratin 5/6 and Ki 67
- Study of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor Expression by Immunohistochemistry in Breast Carcinoma
Abstract
Cholesterol and the Wnt/β-catenin pathway have an effective role in the proliferation, survival, drug resistance, immune exhaustion, and metastasis of all types of cancer cells. Considering the role of LDLR and LRP6 proteins in cholesterol uptake by cells and activation of Wnt/β-catenin pathway, this study aims to examine the gene expression of LDLR and LRP6 in cell lines of breast cancer. Human breast cancer cell lines MCF7, MD468 and SKBR3 were cultured in suitable conditions and after extracting total RNA from them, real-Time PCR was used to measure the levels of gene expression for LDLR and LRP6. Our results showed that the expression of LDLR and LRP6 genes is significantly increased in MCF7 and MD468 cells compared to SKBR3 cells. These results suggest that LRP6 and LDLR can be considered as a therapeutic target in tumors that have a genetic profile similar to MCF7 and MD468 cells
Other Latest Articles
- The role of miR-133a in silibinin-mediated inhibition of the PI3K/AKT/mTOR pathway in MCF-7 breast carcinoma cells
- Association study of the polymorphisms rs2228611 of the DNMT1 gene and rs1569686 of the DNMT3B gene with bladder cancer development in a sample of the Algerian population
- Phylogenetic position inferred on SSU rDNA sequence gene and description of a new parasitic cnidarian (Endocnidozoa: Myxobolidae) infecting Markiana nigripinnis (Teleostei: Stevardiinae) from a small marginal lake floodplain, Brazil
- Hijacking the epigenetic mechanisms of A. baumannii
- Analyzing Consumer Cost Efficiency: A Quantitative Study of Travel Agency Bookings in Cabanatuan City
Last modified: 2024-07-01 15:57:17